Este año como novedad, se celebrarán dos sesiones en colaboración con New England Journal of Medicine y el Journal of the American Medical Association
Se presentarán los siguientes estudios:
Sábado, 24 de Marzo del 2012
Late-Breaking Clinical Trials I
Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure: The FOCUS Randomized Trial
Emerson C Perin (Texas Heart Institute, Houston)
Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P): TIMI 50 Trial
David A Morrow (Brigham and Women’s Hospital, Boston, MA)
Domingo, 25 de Marzo del 2012
Late-Breaking Clinical Trials II
Outcomes of Non-Primary PCI at Hospitals With and Without On-site Cardiac Surgery:CPORT-E Trial. Final Medical Outcomes
Thomas Aversano (Johns Hopkins University, Baltimore, MD)
INFUSE-AMI: A 2×2 Factorial, Multicenter, Prospective, Randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI
Gregg W Stone (Columbia University Medical Center, New York, NY)
Randomized Comparison of Adding Cilostazol Versus Doubling the Dose of Clopidogrel after Receiving Percutaneous Coronary Intervention: The HOST-ASSURE Randomized Trial
Kyung Woo Park (Seoul National University Hospital, South Korea)
A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of Acute Coronary Syndromes: Main Results from the BRIDGE-ACS Cluster Randomized Trial
Otavio Berwanger (Research Institute-Cardiac Hospital, São Paulo, Brazil)
Lunes, 26 de Marzo del 2012
Sesión conjunta ACC/New England Journal of Medicine
CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study
Andre Lamy (McMaster University, Hamilton, ON)
ACRIN PA 4005: Multicenter Randomized Controlled Study of a Rapid “Rule Out” Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk ED Patients With Potential Acute Coronary Syndromes
Harold Litt (University of Pennsylvania, Philadelphia)
Oral Rivaroxaban Alone for Symptomatic Pulmonary Embolism: The EINSTEIN PE Study
Harry Roger Buller (Academic Medical Center, Amsterdam, the Netherlands)
Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of the PARTNER Trial
Martin Leon (Columbia University Medical Center, New York, NY)
Late-Breaking Clinical Trials IV
Comparison of Bariatric Surgical Procedures and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Patients with Moderate Obesity: 1-year STAMPEDE Trial Results
Philip Raymond Schauer(Cleveland Clinic, OH)
A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life
Brian Anthony Ference (Wayne State University School of Medicine, Detroit, MI)
A Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, REGN727/SAR236553, in Patients with Primary Hypercholesterolemia (NCT: 01288443)
James McKenney (National Clinical Research, Richmond,VA)
Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole
Michele Brignole (Ospedali del Tigullio, Lavagna, Italy)
Martes, 27 de Marzo del 2012
Sesión conjunta ACC/Journal of the American Medical Association
Survival after PCI or CABG in Older Patients with Stable Multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies
William S Weintraub (Christiana Healthcare Services, Newark, DE)
Multicenter Randomized Comparative Effectiveness Trial of Cardiac CT vs Alternative Triage Strategies in Acute Chest Pain Patients in the Emergency Department: Results from the ROMICAT II Trial
Udo Hoffmann(Massachusetts General Hospital, Boston)
Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care) Trial: A Double-Blind Randomized Controlled Trial of Intravenous Glucose, Insulin, and Potassium (GIK) for Acute Coronary Syndromes in Emergency Medical Services
Harry P Selker(Tufts Medical Center, Boston, MA)
Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT Study)
Mohsen Sharifi (Arizona Cardiovascular Consultants, Mesa)